Cargando…

Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis

BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Yani, Liu, Shan, Zhang, Zheyuan, Hu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152125/
https://www.ncbi.nlm.nih.gov/pubmed/34034750
http://dx.doi.org/10.1186/s12944-021-01481-1
_version_ 1783698540245024768
author Ke, Yani
Liu, Shan
Zhang, Zheyuan
Hu, Jie
author_facet Ke, Yani
Liu, Shan
Zhang, Zheyuan
Hu, Jie
author_sort Ke, Yani
collection PubMed
description BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There may be some correlation between ANGPTLs and MAFLD, but the specific correlation is unclear. This study aims to explore the predictive role of ANGPTLs in MAFLD and its progression. METHODS: Seven databases (PubMed, EMBASE, Cochrane Library, CNKI, WANFANG, CBM and Clinicaltrials.gov) were searched with free terms and MeSH terms. The random-effects model was used to pool the data, and Standardized Mean Difference (SMD) and 95% confidence intervals (CI) were taken as the overall outcome. No language restrictions existed in the article selection. RevMan 5.3, Stata 16 and MetaXL software were applied to analyse the data and the GRADE system was utilized to assess the certainty of evidence. RESULTS: After reviewing 823 related articles, 13 studies (854 cases and 610 controls) met the inclusion criteria, and contributed to this meta-analysis. The results showed that circulating ANGPTL8 level was significantly elevated in the MAFLD group than in the healthy control group (SMD = 0.97 pg/mL, 95%CI: 0.77, 1.18). Conversely, there was no significant difference in the ANGPTL4 (SMD = 0.11 ng/mL, 95%CI: − 0.32, 0.54) and ANGPTL3 (SMD = − 0.95 ng/mL, 95%CI: − 4.38, 2.48) between the two groups. Subgroup analysis showed that: 1) the MAFLD group had significantly higher ANGPTL8 levels than the healthy control group in Asian and other races; 2) the ANGPTL8 levels in Body Mass Index (BMI) > 25 kg/m(2) patients with MAFLD were higher than those in the healthy control group; 3) the higher ANGPTL8 levels were observed in moderate to severe MAFLD group than the healthy control group. Meta-regression demonstrated that BMI might effectively explain the high heterogeneity. No significant publication bias existed (P > 0.05). The certainty of evidence was assessed as very low by the GRADE system. CONCLUSIONS: The ANGPTLs may be related to MAFLD. The increased ANGPTL8 level may be positively correlated with different situations of MAFLD, which may act as a potential indicator to monitor the development trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01481-1.
format Online
Article
Text
id pubmed-8152125
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81521252021-05-26 Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis Ke, Yani Liu, Shan Zhang, Zheyuan Hu, Jie Lipids Health Dis Review BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There may be some correlation between ANGPTLs and MAFLD, but the specific correlation is unclear. This study aims to explore the predictive role of ANGPTLs in MAFLD and its progression. METHODS: Seven databases (PubMed, EMBASE, Cochrane Library, CNKI, WANFANG, CBM and Clinicaltrials.gov) were searched with free terms and MeSH terms. The random-effects model was used to pool the data, and Standardized Mean Difference (SMD) and 95% confidence intervals (CI) were taken as the overall outcome. No language restrictions existed in the article selection. RevMan 5.3, Stata 16 and MetaXL software were applied to analyse the data and the GRADE system was utilized to assess the certainty of evidence. RESULTS: After reviewing 823 related articles, 13 studies (854 cases and 610 controls) met the inclusion criteria, and contributed to this meta-analysis. The results showed that circulating ANGPTL8 level was significantly elevated in the MAFLD group than in the healthy control group (SMD = 0.97 pg/mL, 95%CI: 0.77, 1.18). Conversely, there was no significant difference in the ANGPTL4 (SMD = 0.11 ng/mL, 95%CI: − 0.32, 0.54) and ANGPTL3 (SMD = − 0.95 ng/mL, 95%CI: − 4.38, 2.48) between the two groups. Subgroup analysis showed that: 1) the MAFLD group had significantly higher ANGPTL8 levels than the healthy control group in Asian and other races; 2) the ANGPTL8 levels in Body Mass Index (BMI) > 25 kg/m(2) patients with MAFLD were higher than those in the healthy control group; 3) the higher ANGPTL8 levels were observed in moderate to severe MAFLD group than the healthy control group. Meta-regression demonstrated that BMI might effectively explain the high heterogeneity. No significant publication bias existed (P > 0.05). The certainty of evidence was assessed as very low by the GRADE system. CONCLUSIONS: The ANGPTLs may be related to MAFLD. The increased ANGPTL8 level may be positively correlated with different situations of MAFLD, which may act as a potential indicator to monitor the development trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01481-1. BioMed Central 2021-05-25 /pmc/articles/PMC8152125/ /pubmed/34034750 http://dx.doi.org/10.1186/s12944-021-01481-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Ke, Yani
Liu, Shan
Zhang, Zheyuan
Hu, Jie
Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title_full Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title_fullStr Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title_full_unstemmed Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title_short Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
title_sort circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152125/
https://www.ncbi.nlm.nih.gov/pubmed/34034750
http://dx.doi.org/10.1186/s12944-021-01481-1
work_keys_str_mv AT keyani circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis
AT liushan circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis
AT zhangzheyuan circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis
AT hujie circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis